Posts

Showing posts with the label ANDA FILINGS

Subscribe Now!

Understand Pharma Sector in Detail - Pharma Primer

Image
"Get ready for your comprehensive guide to understanding the fundamentals and specifics of the Indian Pharma Sector." Pharmaceutical Industry The following article provides an overview of the Indian Pharmaceutical Industry, aiming to familiarize readers with the terminology and jargon used in the industry. It briefly touches upon terms such as API, Intermediates, CDMOs/CRAMs, PARA Filings, Innovator drugs, Generic drugs, and life cycle development. The Indian pharmaceutical market is unique in several ways. Branded generics make up 70 to 80% of the retail market, and India is the largest exporter of generic drugs globally. Local pharmaceutical companies have a strong position due to their formulation development capabilities and early investments. Additionally, the market has low price levels driven by intense competition. Although India ranks tenth globally in terms of value, it is ranked third in volumes. These characteristics create both opportunities and challenges for th...

Neuland Labs Ltd - Q3FY21 Result Update

Image
Neuland Labs Ltd Q3FY21 Result Update Twitter Handle: @shuchi_nahar   Link to Company Overview of Neuland Labs in detail: https://myweekendspot.blogspot.com/2020/09/neuland-labs-company-snapshot.html The company has announced consecutive another strong quarter of top-line and bottom-line performance. The revenue at Rs.245.6 crores was a 20% improvement over the corresponding quarter of the last fiscal while the margins have shown an upward trajectory and closed at 19.0%. This was driven by growth across the GDS and CMS verticals. The company remains confident of its long-term growth aspirations as well as its margin resilience.  • Total income increased by 20.0% in Q3FY21 on account of secular growth in GDS and CMS. • Prime segment continues growth led by Levetiracetam and Mirtazapine. • Speciality business had a stable quarter led by Deferasirox and Dorzolamide. • CMS business witnessed growth in scale-up projects and higher projects coming up for validation. • Two ...

Strides Pharma (STAR) - Company Snapshot

Image
  Strides Pharma Sciences Ltd.(STAR) - Company Overview Twitter Handle:  shuchi_nahar       1)  Company Profile Strides is a global pharmaceutical company headquartered in Bangalore. The Company has two business verticals, Regulated Markets and Emerging Markets. The Company has a global manufacturing footprint with 7 manufacturing facilities spread across three continents including 5 facilities for Regulated Markets and 2 facilities for Emerging Markets. The Company has a strong R&D infrastructure in India with global filing capabilities and a strong commercial footprint across 100 countries. The core generic pharma business of Strides is led by IP-driven product licensing and marketing and distribution partnerships across the globe. Strides have created an exhaustive pipeline of generics across varied formats and domains including oral dosage forms and topicals. The company is among the leading players worldwide in soft gel capsules. Their domain s...